4 Recruiting Metastatic Castration-resistant Prostate Cancer Phase 1 / Phase 2 Clinical Trials

Active phase 1 / phase 2 studies for metastatic castration-resistant prostate cancer enrolling across the USA. Verify eligibility and contact site coordinators.

All Metastatic Castration-resistant Prostate Cancer studies

Phase 1 / Phase 2 Studies for Metastatic Castration-resistant Prostate Cancer

🔵 Active, Not Recruiting Phase1 / Phase2

A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer

📍 Helen Diller Family Comprehensive Cancer Center University of California San Francisco — San Francisco, California

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC

📍 UC Davis Comprehensive Cancer Center — Sacramento, California

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer

📍 University of California, San Francisco — San Francisco, California

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer

📍 Stanford University Medical Center - Blake Wilbur Drive — Palo Alto, California

View Study & Checklist ➔